You are here

Jeff Cottrell


Chan B, Cottrell JR, Li B et al. Development of a high throughput AlphaScreen assay to screen for modulators of synapsin I in primary neurons. J Biomol Screen. 2013;19:205–214.

Cottrell JR, Li B, Kyun JW et al. Working memory deficits are associated with impaired high frequency synaptic and network activity in conditional calcineurin knockout mice. J Neurosci. 2013;33(27):10938–10949.

Hempel CM, Sivula M, Levenson JM et al. A system for performing high throughput assays of synaptic function. PLoS One. 2011;6(10):e25999.

Jeff Cottrell, Ph.D.

Jeff Cottrell is director of translational research at the Stanley Center for Psychiatric Research at Broad Institute. He leads a group focused on translating research on the genetics of psychiatric disease into strategies for the development of novel, mechanism-based therapeutics. His group develops and implements screening assays of disease-associated targets for drug discovery programs and studies the role of disease-linked genes in neuronal biochemical signaling for the identification of new targets and assays.

Cottrell came to the Broad Institute in June 2015 after nearly 11 years at Galenea, a biotech startup in the Boston area focused on treatments for CNS disorders. He holds a Ph.D. in neuroscience from MIT and an A.B. in psychology from Harvard University.

Contact Jeff Cottrell via email at

December 2016